Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last days
Enjoy this offer
* See conditions under "Our services"

Valuation: Photocure ASA

Market Cap 1.54B 163M 140M 129M 121M 225M 15.57B 231M 1.53B 596M 7.52B 610M 597M 25.93B P/E Ratio 2026 *
19x
P/E Ratio 2027 * 30.2x
Enterprise Value 1.22B 129M 111M 102M 95.71M 178M 12.3B 182M 1.21B 471M 5.95B 482M 472M 20.49B EV / Sales 2026 *
1.92x
EV / Sales 2027 * 1.74x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-0.64%
1 week-16.37%
Current month-16.37%
1 month-12.59%
3 months-11.71%
6 months+10.75%
Current year-11.71%
1 week 6.18
Extreme 6.18
6.73
1 month 6.18
Extreme 6.18
7.39
Current year 6.18
Extreme 6.18
7.39
1 year 5.15
Extreme 5.15
7.39
3 years 4.32
Extreme 4.32
7.39
5 years 4.21
Extreme 4.21
17.57
10 years 3
Extreme 3
17.57
Manager TitleAgeSince
Chief Executive Officer - 2018-10-31
Chief Executive Officer - 2018-06-30
Chief Tech/Sci/R&D Officer - 2021-07-31
Director TitleAgeSince
Director/Board Member - 2021-12-31
Chairman - 2023-09-26
Director/Board Member - 2024-05-22
Change 5-day change 1-year change 3-year change Capi.($)
-0.64%-16.37% - - 161M
+2.16%+7.62%+43.83%+160.28% 1,013B
-0.07%+6.76%+52.34%+48.95% 574B
-0.08%+3.52%+18.61%+62.66% 397B
+0.77%+4.97%+21.24%+15.95% 324B
+0.85%+2.79%+24.89%+15.93% 280B
+2.10%+7.06%+24.57%+34.79% 273B
+4.84%+4.68%+20.66%+61.85% 182B
-0.19%+3.96%-45.64%-48.23% 194B
+3.61%-2.42%+14.33%+61.12% 151B
Average +1.13%+2.65%+19.42%+45.92% 376.52B
Weighted average by Cap. +0.67%+3.99%+29.36%+72.50%

Financials

2026 *2027 *
Net sales 634M 66.97M 57.8M 53.15M 49.88M 92.83M 6.41B 94.95M 631M 245M 3.1B 251M 246M 10.68B 676M 71.3M 61.53M 56.59M 53.1M 98.83M 6.83B 101M 672M 261M 3.3B 268M 262M 11.37B
Net income 81.5M 8.6M 7.42M 6.83M 6.41M 11.92M 824M 12.2M 81.02M 31.52M 398M 32.29M 31.59M 1.37B 51M 5.38M 4.65M 4.27M 4.01M 7.46M 515M 7.63M 50.7M 19.72M 249M 20.21M 19.77M 858M
Net Debt -323M -34.09M -29.42M -27.06M -25.39M -47.25M -3.26B -48.34M -321M -125M -1.58B -128M -125M -5.44B -365M -38.53M -33.25M -30.58M -28.69M -53.4M -3.69B -54.62M -363M -141M -1.78B -145M -141M -6.14B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
26-06-08 6.180 $ -0.64% 3,650
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
57.90NOK
Average target price
85.00NOK
Spread / Average Target
+46.80%

Quarterly revenue - Rate of surprise

- 40% : Our Best Subscriber-Only Tools to Spot Tomorrow’s Top Investments!
d
:
:
SEIZE THE OFFER!